Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Salvato in:
| Autori principali: | , , , , , , , , , , , , , , |
|---|---|
| Natura: | Article (Journal) Book/Monograph |
| Lingua: | inglese |
| Pubblicazione: |
London
BioMed Central
18 Jun. 2019
Heidelberg Universitätsbibliothek Heidelberg 18 Jun. 2019 |
| DOI: | 10.1186/s13045-019-0727-4 |
| Accesso online: | Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13045-019-0727-4 Resolving-System, kostenfrei, Volltext: https://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-263736 Verlag, kostenfrei, Volltext: http://www.ub.uni-heidelberg.de/archiv/26373 |
| Note sull'autore: | Francesco Saraceni, Myriam Labopin, Arne Brecht, Nicolaus Kröger, Matthias Eder, Johanna Tischer, Hélène Labussière-Wallet, Hermann Einsele, Dietrich Beelen, Donald Bunjes, Dietger Niederwieser, Tilmann Bochtler, Bipin N. Savani, Mohamad Mohty and Arnon Nagler |
| Descrizione del documento: | In: Journal of Hematology & Oncology, 12 (2019), Nr. 44. pp. 1-10. ISSN 1756-8722 |
|---|---|
| Descrizione fisica: | Online Resource |
| DOI: | 10.1186/s13045-019-0727-4 |